Abiopharma

🔍 Lockwood-Taylor Patrick (Director)

Company: PERRIGO Co plc (PRGO)

Report Date: 2026-03-06

Detailed Transactions and Holdings:

• Acquired 11,727 shares of Ordinary Shares at $10.72 per share (Direct)
  Date: 2026-03-06 | Code: M | equity_swap_involved: 0 | shares_owned_after: 97,539.00 | transaction_form_type: 4
• Sold 4,240 shares of Ordinary Shares at $10.72 per share (Direct)
  Date: 2026-03-06 | Code: F | equity_swap_involved: 0 | shares_owned_after: 93,299.00 | transaction_form_type: 4
• Acquired 13,839 shares of Ordinary Shares at $10.72 per share (Direct)
  Date: 2026-03-06 | Code: A | equity_swap_involved: 0 | shares_owned_after: 107,138.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 5,003 shares of Ordinary Shares at $10.72 per share (Direct)
  Date: 2026-03-06 | Code: F | equity_swap_involved: 0 | shares_owned_after: 102,135.00 | transaction_form_type: 4
• Sold 11,727 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-06 | Code: M | equity_swap_involved: 0 | shares_owned_after: 11,727.00 | transaction_form_type: 4 | Footnotes: F2, F4, F3, F3

Footnotes:

• F1: Vesting of performance-based restricted stock units granted on July 10, 2023.
• F2: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share.
• F3: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 2 equal annual installments beginning 6 March 2026.
• F4: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share.